Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.25 (-0.89%)
At close: Dec 31, 2025
Genovate Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 10.93 | 25.7 | 29.33 | -12.32 | 0.37 | 38.73 | Upgrade |
Depreciation & Amortization | 36.65 | 35.73 | 35.14 | 35.08 | 34.74 | 34.08 | Upgrade |
Other Amortization | 2.38 | 2.1 | 1.41 | 1 | 1.08 | 1.13 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.09 | Upgrade |
Loss (Gain) From Sale of Investments | -0.49 | -0.47 | -0.45 | -0.07 | - | -0 | Upgrade |
Loss (Gain) on Equity Investments | 1.75 | 0.96 | 3.88 | -0.29 | -0.14 | 1.63 | Upgrade |
Stock-Based Compensation | - | - | - | 11.7 | - | - | Upgrade |
Provision & Write-off of Bad Debts | -0 | -0 | -0.01 | -0 | 0 | -0.03 | Upgrade |
Other Operating Activities | -4.92 | 2.88 | -2.34 | -0.58 | 1.49 | -4.7 | Upgrade |
Change in Accounts Receivable | 13.06 | -2.95 | 13.13 | 0.24 | -29.87 | 17.52 | Upgrade |
Change in Inventory | -14.68 | -6.23 | 6.22 | -5.92 | -0.3 | -4.01 | Upgrade |
Change in Accounts Payable | -10.19 | 7.42 | -12.93 | 10.92 | 11.65 | -26.04 | Upgrade |
Change in Unearned Revenue | 0.19 | -2.94 | 0.17 | 0.71 | 0.11 | 1.39 | Upgrade |
Change in Other Net Operating Assets | -0.8 | -2.6 | 26.04 | -32.04 | -23.38 | 7.3 | Upgrade |
Operating Cash Flow | 29.94 | 55.11 | 84.78 | 1.51 | -17.26 | 87.08 | Upgrade |
Operating Cash Flow Growth | -54.49% | -35.00% | 5514.70% | - | - | 95.98% | Upgrade |
Capital Expenditures | -57.5 | -30.78 | -27.98 | -23.55 | -17.96 | -27.01 | Upgrade |
Sale of Property, Plant & Equipment | 16.14 | 16.14 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -2.65 | -0.6 | -5.37 | -0.47 | -0.17 | -0.15 | Upgrade |
Investment in Securities | -24.23 | 43.41 | -41.15 | 17.03 | 57.12 | 9.46 | Upgrade |
Other Investing Activities | -4.46 | 1.46 | -4.2 | 1.23 | -2.09 | 2.6 | Upgrade |
Investing Cash Flow | -72.7 | 29.64 | -78.68 | -5.75 | 36.9 | -15.1 | Upgrade |
Long-Term Debt Repaid | - | -1.05 | -1.26 | -1.22 | -1.23 | -1.22 | Upgrade |
Net Debt Issued (Repaid) | -0.86 | -1.05 | -1.26 | -1.22 | -1.23 | -1.22 | Upgrade |
Issuance of Common Stock | - | - | - | 38.88 | - | - | Upgrade |
Repurchase of Common Stock | -5.3 | -25.72 | - | - | - | - | Upgrade |
Common Dividends Paid | -11.15 | -16.41 | -19.14 | -37.76 | -43.36 | -48.22 | Upgrade |
Other Financing Activities | 0.05 | -0.01 | 0.16 | 0.06 | 0.18 | - | Upgrade |
Financing Cash Flow | -17.27 | -43.18 | -20.23 | -0.04 | -44.41 | -49.44 | Upgrade |
Net Cash Flow | -60.03 | 41.57 | -14.13 | -4.28 | -24.77 | 22.54 | Upgrade |
Free Cash Flow | -27.57 | 24.34 | 56.81 | -22.04 | -35.22 | 60.07 | Upgrade |
Free Cash Flow Growth | - | -57.16% | - | - | - | 221.66% | Upgrade |
Free Cash Flow Margin | -5.61% | 4.76% | 10.75% | -5.02% | -8.11% | 12.71% | Upgrade |
Free Cash Flow Per Share | -0.24 | 0.21 | 0.49 | -0.19 | -0.31 | 0.53 | Upgrade |
Cash Interest Paid | 0.74 | 0.52 | 0.27 | 0.28 | 0.25 | 0.25 | Upgrade |
Cash Income Tax Paid | 6 | 2.34 | 3.39 | 3.45 | 1.73 | 7.09 | Upgrade |
Levered Free Cash Flow | -36.36 | 27.83 | 58.76 | -3.69 | -23.57 | 33.59 | Upgrade |
Unlevered Free Cash Flow | -35.9 | 28.15 | 58.92 | -3.51 | -23.41 | 33.75 | Upgrade |
Change in Working Capital | -16.36 | -11.78 | 17.82 | -33.02 | -54.8 | 16.15 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.